Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression

Research output: Contribution to journalArticle

406 Scopus citations

Abstract

For antiretroviral therapy, the 95% adherence "threshold" is based on nucloside-exposed patients who are receiving partially suppressive, unboosted protease inhibitor regimens. Using unannounced pill counts and electronic medication monitoring, viral suppression is common with a 54%-100% mean adherence level to nonnucleoside reverse-transcriptase-inhibitor regimens. Although perfect adherence is an important goal, viral suppression is possible with moderate adherence to potent regimens.

Original languageEnglish (US)
Pages (from-to)939-941
Number of pages3
JournalClinical Infectious Diseases
Volume43
Issue number7
DOIs
StatePublished - Oct 1 2006
Externally publishedYes

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression'. Together they form a unique fingerprint.

  • Cite this